Our results showed that the immunoreactivity of CtBP2 and Ki-67 was weak in the nucleus of (Figure 1Aa, 1Ac) mammary epithelial and myoepithelial cells in tissue samples from benign breast disease. This evidence concerns the gene MKI67 and breast fibrocystic disease.